Functional capacity testing in patients with pulmonary hypertension (PH) using the one-minute sit-to-stand test (1-min STST).
Journal
PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081
Informations de publication
Date de publication:
2023
2023
Historique:
received:
20
11
2022
accepted:
19
02
2023
entrez:
9
3
2023
pubmed:
10
3
2023
medline:
14
3
2023
Statut:
epublish
Résumé
The one-minute sit-to-stand-test (1-min STST) is a quick, space saving test to evaluate functional capacity. Exercise testing plays an important role in the long-term follow-up of pulmonary hypertension (PH) patients and is currently evaluated using the six-minute-walk-test (6MWT). The aim of the study was to assess the convergent validity of the 1-min STST in patients with PH and its association with markers of PH severity. We evaluated 106 PH patients with the 1-min-STST and 6MWT and measured cardiorespiratory parameters (heart rate, blood pressure, oxygen saturation) before and after test conduction. N-terminal pro brain-type natriuretic peptide (NT-proBNP), WHO functional class (WHO-FC) and mean pulmonary artery pressure (mPAP) were defined as markers of PH severity. Strong correlation was found between performances of 1-min STST and 6MWT (r = .711, p < .001), indicating convergent validity. Both tests were inversely associated with NT-proBNP (STST: r = -.405, p < .001; 6MWT: r = -.358, p < .001), WHO-FC (STST: r = -.591, p < .001; 6MWT: r = -.643, p < .001) and mPAP (STST: r = -.280, p < .001; 6MWT: r = -.250, p < .001). Significant changes in cardiorespiratory parameters were observed in both tests (all p < 0.001). Further the post-exercise cardiorespiratory parameters correlated strongly between the 1-min STST and 6MWT (all r ≥ .651, all p < .001). The 1-min STST demonstrated good convergent validity with the 6MWT and was associated with markers of PH severity. Furthermore, both exercise tests caused similar cardiorespiratory responses.
Sections du résumé
BACKGROUND
The one-minute sit-to-stand-test (1-min STST) is a quick, space saving test to evaluate functional capacity. Exercise testing plays an important role in the long-term follow-up of pulmonary hypertension (PH) patients and is currently evaluated using the six-minute-walk-test (6MWT). The aim of the study was to assess the convergent validity of the 1-min STST in patients with PH and its association with markers of PH severity.
METHODS
We evaluated 106 PH patients with the 1-min-STST and 6MWT and measured cardiorespiratory parameters (heart rate, blood pressure, oxygen saturation) before and after test conduction. N-terminal pro brain-type natriuretic peptide (NT-proBNP), WHO functional class (WHO-FC) and mean pulmonary artery pressure (mPAP) were defined as markers of PH severity.
RESULTS
Strong correlation was found between performances of 1-min STST and 6MWT (r = .711, p < .001), indicating convergent validity. Both tests were inversely associated with NT-proBNP (STST: r = -.405, p < .001; 6MWT: r = -.358, p < .001), WHO-FC (STST: r = -.591, p < .001; 6MWT: r = -.643, p < .001) and mPAP (STST: r = -.280, p < .001; 6MWT: r = -.250, p < .001). Significant changes in cardiorespiratory parameters were observed in both tests (all p < 0.001). Further the post-exercise cardiorespiratory parameters correlated strongly between the 1-min STST and 6MWT (all r ≥ .651, all p < .001).
CONCLUSION
The 1-min STST demonstrated good convergent validity with the 6MWT and was associated with markers of PH severity. Furthermore, both exercise tests caused similar cardiorespiratory responses.
Identifiants
pubmed: 36893125
doi: 10.1371/journal.pone.0282697
pii: PONE-D-22-31968
pmc: PMC9997887
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0282697Informations de copyright
Copyright: © 2023 Kronberger et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
Thorax. 2013 Nov;68(11):1015-20
pubmed: 23783372
Methodist Debakey Cardiovasc J. 2021 Jul 01;17(2):92-100
pubmed: 34326928
Int J Chron Obstruct Pulmon Dis. 2016 Oct 19;11:2609-2616
pubmed: 27799759
Am J Respir Crit Care Med. 2002 Jul 1;166(1):111-7
pubmed: 12091180
J Cardiol. 2022 Nov;80(5):432-440
pubmed: 35570097
Int J Public Health. 2013 Dec;58(6):949-53
pubmed: 23974352
Swiss Med Wkly. 2002 Dec 14;132(43-44):623-8
pubmed: 12587046
Eur Respir J. 1999 Aug;14(2):270-4
pubmed: 10515400
Eur Heart J. 2022 Oct 11;43(38):3618-3731
pubmed: 36017548
PLoS One. 2021 Feb 12;16(2):e0246781
pubmed: 33577586
Circulation. 2019 May 21;139(21):2440-2450
pubmed: 30982349
Chest. 2006 May;129(5):1313-21
pubmed: 16685024
Clin Respir J. 2018 Mar;12(3):1247-1256
pubmed: 28621019
Qual Life Res. 2006 Feb;15(1):103-15
pubmed: 16411035
J Gen Psychol. 2003 Apr;130(2):149-68
pubmed: 12773018
J Hum Reprod Sci. 2011 Jan;4(1):8-11
pubmed: 21772732
Ther Adv Respir Dis. 2018 Jan-Dec;12:1753466618793028
pubmed: 30091679
Circ Rep. 2020 Mar 20;2(4):249-254
pubmed: 33693237
Maedica (Bucur). 2012 Jan;7(1):30-7
pubmed: 23118817
Heart Fail Clin. 2018 Jul;14(3):467-477
pubmed: 29966642
Clin Chim Acta. 2003 Feb;328(1-2):87-90
pubmed: 12559602
J Cyst Fibros. 2016 Mar;15(2):223-6
pubmed: 26363563
Respir Care. 2020 Apr;65(4):437-443
pubmed: 31641072
Circ J. 2019 Mar 25;83(4):842-945
pubmed: 30853682
Medicine (Baltimore). 2018 Jan;97(1):e9489
pubmed: 29505521
Ann Thorac Med. 2015 Oct-Dec;10(4):269-73
pubmed: 26664565
Int J Cardiol. 2020 Apr 1;304:159-163
pubmed: 31980271
Med Sci Sports Exerc. 1982;14(5):377-81
pubmed: 7154893
Pulm Circ. 2021 Mar 29;11(2):2045894021999955
pubmed: 33854767
Eur Respir J. 2017 Mar 2;49(3):
pubmed: 28254766
Circulation. 2010 Jul 13;122(2):164-72
pubmed: 20585012
Respiration. 2021;100(7):571-579
pubmed: 33849043
Anatol J Cardiol. 2015 Mar;15(3):249-54
pubmed: 25880178
Heart Lung. 2022 Sep-Oct;55:134-139
pubmed: 35567840
Respir Med. 2007 Feb;101(2):286-93
pubmed: 16806873